ArticleCureus2025
Idiopathic Hyperprolactinemia: Clinical Presentation, Diagnosis, Management, and Clinical Outcome.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Breaking Barriers to Motherhood: Successful Conception and Term Delivery in Infertile Women with Hyperprolactinemia - Two Case Reports.International journal of women's health · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycystic ovary syndrome (PCOS) is a multifactorial endocrine disorder often presenting with menstrual irregularities, hyperandrogenism, and metabolic dysfunction. Hyperprolactinemia, characterized by elevated prolactin levels, may share overlapping features with PCOS and complicate diagnosis. When these two conditions coexist, they present unique clinical and management challenges. A 25-year-old woman with a history of PCOS presented with amenorrhea, progressive weight gain, and irregular menstrual cycles. Laboratory investigations revealed persistently elevated prolactin levels, while pituitary imaging ruled out structural abnormalities. The patient received lifestyle modification advice and dopamine agonist therapy, with continuous monitoring of hormonal, metabolic, and psychological parameters. This case highlights the diagnostic complexity of idiopathic hyperprolactinemia occurring in the context of PCOS, and emphasizes the importance of a multidisciplinary approach to management. Further clinical observations are needed to understand the neuropsychiatric effects of prolactin dysregulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.